APA (7th ed.) Citation

T, K., S, K., T, K., BJ, M., M, S., & H, N. (2025). Feasibility of enzalutamide on patients with recurrent non-muscle-invasive bladder cancer with marker tumors: Phase I study. BMC research notes, 18(1), 47. https://doi.org/10.1186/s13104-025-07128-z

Chicago Style (17th ed.) Citation

T, Kawahara, Kandori S, Kojima T, Mathis BJ, Shiga M, and Nishiyama H. "Feasibility of Enzalutamide on Patients with Recurrent Non-muscle-invasive Bladder Cancer with Marker Tumors: Phase I Study." BMC Research Notes 18, no. 1 (2025): 47. https://doi.org/10.1186/s13104-025-07128-z.

MLA (9th ed.) Citation

T, Kawahara, et al. "Feasibility of Enzalutamide on Patients with Recurrent Non-muscle-invasive Bladder Cancer with Marker Tumors: Phase I Study." BMC Research Notes, vol. 18, no. 1, 2025, p. 47, https://doi.org/10.1186/s13104-025-07128-z.